| Tang Kevin |
Non-Executive Director |
Aurinia Pharmaceuticals Inc. (AUPH)
|
2025-08-05 |
$10.45 |
0.0% |
1,300,000
|
$13,590,000 |
| Tang Kevin |
Non-Executive Director |
Aurinia Pharmaceuticals Inc. (AUPH)
|
2025-03-04 |
$7.95 |
0.0% |
1,600,000
|
$12,713,126 |
| Tang Kevin |
Non-Executive Director |
Aurinia Pharmaceuticals Inc. (AUPH)
|
2024-12-09 |
$9.02 |
0.0% |
1,200,000
|
$10,822,000 |
| Tang Kevin |
Non-Executive |
Singular Genomics Systems, Inc. (OMIC)
|
2024-09-18 |
$14.75 |
0.0% |
122,416
|
$1,806,220 |
| Tang Kevin C |
Non-Executive |
Rain Oncology Inc. (RAIN)
|
2023-10-13 |
$0.98 |
23.2% |
284,145
|
$279,030 |
| Tang Kevin C |
Non-Executive |
Rain Oncology Inc. (RAIN)
|
2023-06-01 |
$1.06 |
13.6% |
1,088,273
|
$1,158,764 |
| Tang Kevin C |
Non-Executive |
TCR2 THERAPEUTICS INC. (TCRR)
|
2023-05-25 |
$1.72 |
-14.0% |
50,000
|
$86,000 |
| Tang Kevin C |
Non-Executive |
TCR2 THERAPEUTICS INC. (TCRR)
|
2023-05-12 |
$1.95 |
-24.1% |
44,948
|
$87,649 |
| Tang Kevin C |
Non-Executive |
TCR2 THERAPEUTICS INC. (TCRR)
|
2023-05-10 |
$1.95 |
-24.1% |
83,988
|
$163,777 |
| Tang Kevin C |
Non-Executive |
TCR2 THERAPEUTICS INC. (TCRR)
|
2023-05-05 |
$1.89 |
-21.8% |
289,577
|
$547,944 |
| Tang Kevin C |
Non-Executive |
Jounce Therapeutics, Inc. (JNCE)
|
2023-03-14 |
$1.00 |
88.1% |
85,987
|
$85,958 |
| Tang Kevin C |
Non-Executive |
Aptevo Therapeutics Inc. (APVO)
|
2020-11-06 |
$563169.10 |
-100.0% |
44
|
$24,849,231 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-37.4% |
$-24,742,657 |
$66,189,698 |